PROCTER & GAMBLE HEALTH | SEQUENT SCIENTIFIC | PROCTER & GAMBLE HEALTH/ SEQUENT SCIENTIFIC |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | -25.3 | - | View Chart |
P/BV | x | 10.6 | 4.9 | 217.5% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH SEQUENT SCIENTIFIC |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
SEQUENT SCIENTIFIC Mar-23 |
PROCTER & GAMBLE HEALTH/ SEQUENT SCIENTIFIC |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 156 | 3,441.7% | |
Low | Rs | 3,883 | 62 | 6,283.2% | |
Sales per share (Unadj.) | Rs | 740.7 | 57.0 | 1,300.3% | |
Earnings per share (Unadj.) | Rs | 138.2 | -4.9 | -2,826.8% | |
Cash flow per share (Unadj.) | Rs | 155.2 | -2.7 | -5,838.8% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 25.8 | 1,737.9% | |
Shares outstanding (eoy) | m | 16.60 | 249.43 | 6.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 1.9 | 326.7% | |
Avg P/E ratio | x | 33.5 | -22.3 | -150.3% | |
P/CF ratio (eoy) | x | 29.8 | -41.0 | -72.8% | |
Price / Book Value ratio | x | 10.3 | 4.2 | 244.4% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 27,151 | 282.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 2,584 | 79.8% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 14,209 | 86.5% | |
Other income | Rs m | 184 | 64 | 287.8% | |
Total revenues | Rs m | 12,480 | 14,273 | 87.4% | |
Gross profit | Rs m | 3,247 | -528 | -614.5% | |
Depreciation | Rs m | 281 | 557 | 50.5% | |
Interest | Rs m | 8 | 355 | 2.2% | |
Profit before tax | Rs m | 3,142 | -1,377 | -228.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | -157 | -540.3% | |
Profit after tax | Rs m | 2,295 | -1,220 | -188.1% | |
Gross profit margin | % | 26.4 | -3.7 | -710.1% | |
Effective tax rate | % | 27.0 | 11.4 | 236.7% | |
Net profit margin | % | 18.7 | -8.6 | -217.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 8,125 | 144.2% | |
Current liabilities | Rs m | 6,791 | 5,588 | 121.5% | |
Net working cap to sales | % | 40.0 | 17.9 | 224.2% | |
Current ratio | x | 1.7 | 1.5 | 118.6% | |
Inventory Days | Days | 263 | 21 | 1,233.5% | |
Debtors Days | Days | 343 | 88 | 392.2% | |
Net fixed assets | Rs m | 10,617 | 7,435 | 142.8% | |
Share capital | Rs m | 166 | 499 | 33.3% | |
"Free" reserves | Rs m | 7,265 | 5,926 | 122.6% | |
Net worth | Rs m | 7,431 | 6,425 | 115.7% | |
Long term debt | Rs m | 0 | 1,828 | 0.0% | |
Total assets | Rs m | 22,330 | 15,661 | 142.6% | |
Interest coverage | x | 409.1 | -2.9 | -14,223.8% | |
Debt to equity ratio | x | 0 | 0.3 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.9 | 60.7% | |
Return on assets | % | 10.3 | -5.5 | -186.8% | |
Return on equity | % | 30.9 | -19.0 | -162.7% | |
Return on capital | % | 42.4 | -12.4 | -342.5% | |
Exports to sales | % | 0 | 1.8 | 0.0% | |
Imports to sales | % | 13.1 | 1.0 | 1,342.7% | |
Exports (fob) | Rs m | NA | 255 | 0.0% | |
Imports (cif) | Rs m | 1,605 | 138 | 1,161.9% | |
Fx inflow | Rs m | 1,465 | 255 | 574.8% | |
Fx outflow | Rs m | 1,605 | 138 | 1,161.9% | |
Net fx | Rs m | -140 | 117 | -120.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 168 | 1,404.1% | |
From Investments | Rs m | -215 | -650 | 33.1% | |
From Financial Activity | Rs m | -985 | 322 | -305.5% | |
Net Cashflow | Rs m | 1,160 | -159 | -728.7% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 51.8 | 52.8 | 98.2% | |
Indian inst/Mut Fund | % | 20.0 | 13.8 | 145.2% | |
FIIs | % | 6.2 | 6.2 | 101.3% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 47.2 | 102.1% | |
Shareholders | 56,778 | 166,593 | 34.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | SEQUENT SCIENTIFIC | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.24% | 0.45% |
1-Month | -1.15% | 10.04% | 2.55% |
1-Year | 0.73% | 69.29% | 56.14% |
3-Year CAGR | -8.76% | -23.61% | 15.22% |
5-Year CAGR | 4.97% | 11.72% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the SEQUENT SCIENTIFIC share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of SEQUENT SCIENTIFIC the stake stands at 52.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of SEQUENT SCIENTIFIC.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
SEQUENT SCIENTIFIC paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of SEQUENT SCIENTIFIC.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.